| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_04481c68d907208b086a245a70cf0708 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D239-94
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-517
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-00 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D239-94
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-517
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-00 |
| filingDate |
2001-04-19^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_a83ab3b6d0ac56b6601c6f38e034be85 |
| publicationDate |
2003-07-31^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
US-2003144178-A1 |
| titleOfInvention |
Method for inhibiting C-jun expression using JAK-3 inhibitors |
| abstract |
The invention provides a method for inhibiting c-jun activation in mammalian or avian cells comprising contacting the cells with a substance that inhibits the activity of Janus family kinase 3 (JAK-3). The invention also provides a therapeutic method for preventing or treating a pathological condition in a mammal wherein c-jun activation is implicated and inhibition of its activation is desired comprising administering to a mammal in need of such therapy, an effective amount of a substance that inhibits the activity of JAK-3. Novel compounds that are JAK-3 inhibitors, as well as pharmaceutical compositions comprising the compounds are also provided. |
| isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-11179500-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2014065153-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-9895301-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-10265258-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-2678052-A2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-8258145-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2007208044-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-9763866-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-9737469-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-9730877-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2008039479-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-8309562-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-2678052-A4
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-9198911-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2007244113-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2007249601-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-10994157-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-11298570-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-7989462-B2 |
| priorityDate |
1998-06-30^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |